Aggregation is an important quality attribute of many
protein-based biopharmaceuticals, including monoclonal
antibodies (mAbs) and multi-specific antibodies, which
can influence product efficacy and safety. Monitoring of
aggregation levels is therefore essential.
In this webinar you can learn how mass photometry measurement of AAV samples can be applied to GMP-regulated environments such as AAV gene therapy manufacturing.
Read this blog post to learn how mass photometry compares to other AAV analytical methods for measurements of empty/full and heterogeneously loaded AAV capsids.